Jinhe金河品牌怎么样 申请店铺

我要投票 Jinhe金河在饲料添加剂行业中的票数:396 更新时间:2025-08-27
Jinhe金河是哪个国家的品牌?「Jinhe金河」是 金河生物科技股份有限公司 旗下著名品牌。该品牌发源于内蒙古,由创始人王东晓在1990期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Jinhe金河品牌出海!将品牌入驻外推网,定制Jinhe金河品牌推广信息,可以显著提高Jinhe金河产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

Jinhe金河怎么样

金河生物科技股份有限公司是一家生产和销售饲用金霉素及动物保健品为主的民营控股企业,1998年被国家科委认定为“国家重点高新技术企业”,同时也是内蒙古自治区60家重点企业之一。

公司位于青山南麓、黄河之滨的内蒙古托克托县境内,与亚洲最大的火力发电厂——大唐托克托电厂比邻相依,并与中国最大的露天煤矿——准格尔煤田隔(黄)河相望,具有得天独厚的地理优势和资源优势。

公司现拥有国际上先进的发酵生产设备和产品质量检测设备,主要工艺流程全部采用微机自动控制,现有发酵吨位5794立方米,金霉素的发酵规模居世界前列。

其主导产品“牧星”、“金河”牌饲用金霉素目前年生产能力5.3万多吨,连续六次顺利通过美国联邦政府食品与药品管理总署(FDA)的质量验收。

产品主要出口到美国、加拿大、东南亚等国家和地区,同时行销网络遍布国内各省、市(自治区),市场前景十分广阔。

作为一家高新技术企业,金河生物科技股份有限公司近年来得到了迅猛的发展,这主要得益于企业以人为本的发展思路和强大的技术支撑。

通过人才的引进和人力资源的合理配置,使企业逐步形成了自己的人才梯队,在充分发挥人才优势的群体效应的同时,在生产技术领域不断地完善与创新,为企业在知识经济时代异军突起奠定了坚实的基础。

良好的信誉、卓越的品质源于企业严格的管理和对技术创新孜孜不倦的追求。

2001-2002年,企业先后顺利通过了ISO9002质量体系认证和国家兽药企业GMP验收。

从1994年起,企业连续六次顺利通过美国联邦政府食品药品管理总署(FDA)的质量验收,并被国家九部委认定为农业产业化国家重点龙头企业。

金河生物科技股份有限公司在未来的发展进程中,将按照“面向市场、优化结构、整合资源、提高效益”的发展构想,以发酵工业为载体,以调整产品结构为主线,走外延与内涵相结合扩大再生产的科技强企之路,通过与行业精英联盟,实现资产优化和管理升级,结合基因工程等高科技手段的探索与研究,全面提升企业的整体素质和核心竞争力,进一步增强企业的经济实力和发展后劲,为民族工业的繁荣和发展做出新的更大的贡献。

Jinhe Biotechnology Co., Ltd. is a private holding enterprise mainly engaged in the production and sale of feed chlortetracycline and animal health products. In 1998, it was recognized as a "national key high-tech enterprise" by the State Science and Technology Commission, and also one of the 60 key enterprises in Inner Mongolia Autonomous Region. The company is located in Tuoketuo County, Inner Mongolia, on the south foot of Qingshan mountain and the Bank of the Yellow River. It is adjacent to Datang Tuoketuo Power Plant, the largest thermal power plant in Asia, and across the (yellow) River from Jungar coal field, the largest open-pit coal mine in China. It has unique geographical advantages and resource advantages. The company now has advanced fermentation production equipment and product quality testing equipment in the world. The main technological process is all controlled by computer automatically. The current fermentation tonnage is 5794 cubic meters, and the fermentation scale of chlortetracycline ranks the top in the world. Its leading products "muxing" and "Jinhe" brand feed aureomycin currently have an annual production capacity of more than 53000 tons, and have successfully passed the quality acceptance of the United States Federal Food and Drug Administration (FDA) for six consecutive times. The products are mainly exported to the United States, Canada, Southeast Asia and other countries and regions. At the same time, the marketing network is all over the domestic provinces, cities (autonomous regions), and the market prospect is very broad. As a high-tech enterprise, Jinhe Biotechnology Co., Ltd. has developed rapidly in recent years, which is mainly due to the people-oriented development ideas and strong technical support of the enterprise. Through the introduction of talents and the rational allocation of human resources, the enterprise has gradually formed its own talent echelon. While giving full play to the group effect of talent advantages, it has constantly improved and innovated in the field of production technology, laying a solid foundation for the emergence of enterprises in the era of knowledge economy. Good reputation and excellent quality come from the strict management of the enterprise and the tireless pursuit of technological innovation. From 2001 to 2002, the company has successfully passed ISO9002 quality system certification and GMP acceptance of national veterinary drug enterprises. Since 1994, the company has successfully passed the quality acceptance of the United States Federal Food and Drug Administration (FDA) for six consecutive times, and has been recognized as the national key leading enterprise of agricultural industrialization by nine ministries and commissions. In the future development process, Jinhe Biotechnology Co., Ltd. will follow the development concept of "facing the market, optimizing the structure, integrating the resources and improving the efficiency", take the fermentation industry as the carrier, adjust the product structure as the main line, take the road of expanding the renewable production through the combination of extension and connotation, and realize the asset optimization and management upgrading through the alliance with the industry elite, Combined with the exploration and research of high-tech means such as genetic engineering, we will comprehensively improve the overall quality and core competitiveness of enterprises, further enhance the economic strength and development potential of enterprises, and make new and greater contributions to the prosperity and development of national industry.

本文链接: https://brand.waitui.com/cc6e5eebb.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

重仓股名单浮现,多家上市公司二季度获券商增持

当下市场进入上市公司2025年半年报密集披露期,越来越多上市公司半年报中浮现券商机构的身影。Wind数据显示,截至8月26日发稿,A股已有149家公司十大流通股东中出现券商身影,32家公司二季度获其券商大股东增持。二季度券商新进为81家上市公司十大流通股东,一定程度上体现出券商对其投资价值的认同。从券商二季度增持的重仓股行业分布情况看,不少标的来自化工、有色金属、机械设备等行业;从投资角度出发,化工行业白马股、黄金、工程机械等方向获得券商看好。(中证网)

41分钟前

国金证券:中国创新药全面收获,迈向全球舞台

36氪获悉,国金证券研报表示,中国创新药全面收获,ADC、双/多抗技术领先,管线数量全球第一。2023年License out首超License in,金额屡破纪录,海外MNC重金抢购。全球专利悬崖、技术迭代、头对头优效数据共振,肿瘤、自身免疫、减重等赛道国产新药加速出海。集采出清,政策审评、医保、商保全链条支持,业绩边际改善。

41分钟前

债市震幅加大,固收基金经理激辩布局时点

近期股债跷跷板效应再现,债券市场在8月经历了一轮显著调整,不少中长期纯债基金净值承压。展望后市,业内人士表示,从流动性角度来说,人民银行始终表态将维持适度宽松的货币政策,保持流动性充裕。8月以来,面对债券收益率调整,人民银行增量续作买断式逆回购和MLF,显示出对市场流动性的呵护。当前大幅收紧流动性的概率较小,债券收益率大幅上行的概率不大。(中证网)

41分钟前

国金证券:继续重点看好AI算力硬件

36氪获悉,国金证券研报表示,DeepSeek V3.1发布,国产算力迎新机。海外降息预期强化,英伟达、博通季报临近,ASIC需求超预期。GB200/300、B200/300加速出货,谷歌、亚马逊、Meta 2026年ASIC或超700万颗。AI-PCB、覆铜板、钻针、钻孔机、光刻设备全链满产涨价,M8-M9升级价值量倍增,大陆龙头扩产受益。继续看好AI算力硬件、苹果链及自主可控。

41分钟前

美联储降息预期升温,龙头商品有望借势上涨

在美联储主席鲍威尔释放“鸽派”信号后,市场对9月降息预期急剧升温,金融市场迅速作出反应。与此同时,大宗商品市场也因降息预期而备受关注。业内人士表示,从美联储利率路径对商品价格的传导逻辑来看,不同商品因其自身属性不同,对利率变动的反应存在显著差异。在美联储降息预期升温的背景下,那些对美联储政策比较敏感的大宗商品,如铜、白银、黄金等价格有望上涨。(中证网)

42分钟前

本页详细列出关于Jinhe金河的品牌信息,含品牌所属公司介绍,Jinhe金河所处行业的品牌地位及优势。
咨询